OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance
Introduction Cost effectiveness of Barrett’s surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett’s oesophagus but not in surveillance population. The aim of this study is to compare...
Gespeichert in:
Veröffentlicht in: | Gut 2013-06, Vol.62 (Suppl 1), p.A20 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | Suppl 1 |
container_start_page | A20 |
container_title | Gut |
container_volume | 62 |
creator | Bhattacharyya, R Tholoor, S Longcroft-Wheaton, G Basford, P Cowlishaw, D Poller, D Bhandari, P |
description | Introduction Cost effectiveness of Barrett’s surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett’s oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett’s surveillance. Methods Prospective Cohort study comparing two different Barrett’s surveillance strategies. All patients who underwent Barrett’s surveillance between 2008–12 were recorded on a Barrett’s database. All neoplasias were independently reviewed by two GI Pathologists. Barrett’s surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett’s. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher’s exact test was used for statistical analysis. Results N = 982 Barrett’s surveillance gastroscopy between 2008–12. Median age was 66 years & Median Barrett’s length was 4.5 cm (range: 1–20). Male: Female = 3.3:1. Protocol guided Cohort A N = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%). Acetic acid Cohort B N = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett’s surveillance. Abstract OC-046 Table 1 Protocol biopsies cohort(Cohort A) AAC cohort(Cohort B) N=655 N=327 Gain p value HGD 7/655(1.0%) 18/327 (5.5%) 5.5 fold 0.0001 T1 Cancers 3/655 (0.4%) 14/327 (4.2%) 10 fold 0.0001 Total 10/655 (1.5%) 32/327 (9.7%) 6.5 fold 0.0001 Conclusion This is the first report from a large exclusively Barrett’s surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett’s surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of bio |
doi_str_mv | 10.1136/gutjnl-2013-304907.045 |
format | Article |
fullrecord | <record><control><sourceid>proquest_istex</sourceid><recordid>TN_cdi_proquest_journals_2038768336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2038768336</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1086-9dc6a94c75bcd902395d1d94d622edecc1fd1025b212573016d4d4f865806463</originalsourceid><addsrcrecordid>eNo9kc1u1DAUhSMEEkPhFZAl1inXP3Gc5RCgLapamKlgaXlsz-DBiVPbGTG7bngIeLw-CRkFsbqL8-kcXX1F8RrDOcaUv92Ned_7kgCmJQXWQH0OrHpSLDDjoqREiKfFAgDXZVWz5nnxIqU9AAjR4EXx57YtgfHHh19LbbPTaKmdQe33GLqQdBiOaO12vds6rfrsj-iqG2I42IRubBi8Sk6h9zZbnV3o0UrlKVEJ6dANKlqDckCttwfrVT-1etdPC59jyEEHj8wYXb9D71SMNufHh99rtB7jwTo_4dq-LJ5tlU_21b97Vtx9_HDXXpbXtxdX7fK63GAQvGyM5qphuq422jRAaFMZbBpmOCHWWK3x1mAg1YZgUtUUMDfMsK3glQDOOD0r3sy102P3o01Z7sMY-2lREqCi5oLSE1XOlEvZ_pRDdJ2KR6niD8lrWlfy5msrP63ab5eriy8SJh7P_Kbb_6cxyJMxORuTJ2NyNiYnY_QvHg-NiQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038768336</pqid></control><display><type>article</type><title>OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance</title><source>Open Access: PubMed Central</source><source>BMJ Journals Online Archive</source><creator>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</creator><creatorcontrib>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</creatorcontrib><description><![CDATA[Introduction Cost effectiveness of Barrett’s surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett’s oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett’s surveillance. Methods Prospective Cohort study comparing two different Barrett’s surveillance strategies. All patients who underwent Barrett’s surveillance between 2008–12 were recorded on a Barrett’s database. All neoplasias were independently reviewed by two GI Pathologists. Barrett’s surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett’s. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher’s exact test was used for statistical analysis. Results N = 982 Barrett’s surveillance gastroscopy between 2008–12. Median age was 66 years & Median Barrett’s length was 4.5 cm (range: 1–20). Male: Female = 3.3:1. Protocol guided Cohort A N = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%). Acetic acid Cohort B N = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett’s surveillance. Abstract OC-046 Table 1 Protocol biopsies cohort(Cohort A) AAC cohort(Cohort B) N=655 N=327 Gain p value HGD 7/655(1.0%) 18/327 (5.5%) 5.5 fold 0.0001 T1 Cancers 3/655 (0.4%) 14/327 (4.2%) 10 fold 0.0001 Total 10/655 (1.5%) 32/327 (9.7%) 6.5 fold 0.0001 Conclusion This is the first report from a large exclusively Barrett’s surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett’s surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett’s surveillance. Disclosure of Interest None Declared]]></description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gutjnl-2013-304907.045</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Acetic acid ; Acids ; Barrett's esophagus ; Biopsy ; Dysplasia ; Gastroscopy ; Statistical analysis ; Surveillance</subject><ispartof>Gut, 2013-06, Vol.62 (Suppl 1), p.A20</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 © 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://gut.bmj.com/content/62/Suppl_1/A20.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://gut.bmj.com/content/62/Suppl_1/A20.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Bhattacharyya, R</creatorcontrib><creatorcontrib>Tholoor, S</creatorcontrib><creatorcontrib>Longcroft-Wheaton, G</creatorcontrib><creatorcontrib>Basford, P</creatorcontrib><creatorcontrib>Cowlishaw, D</creatorcontrib><creatorcontrib>Poller, D</creatorcontrib><creatorcontrib>Bhandari, P</creatorcontrib><title>OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance</title><title>Gut</title><addtitle>Gut</addtitle><description><![CDATA[Introduction Cost effectiveness of Barrett’s surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett’s oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett’s surveillance. Methods Prospective Cohort study comparing two different Barrett’s surveillance strategies. All patients who underwent Barrett’s surveillance between 2008–12 were recorded on a Barrett’s database. All neoplasias were independently reviewed by two GI Pathologists. Barrett’s surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett’s. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher’s exact test was used for statistical analysis. Results N = 982 Barrett’s surveillance gastroscopy between 2008–12. Median age was 66 years & Median Barrett’s length was 4.5 cm (range: 1–20). Male: Female = 3.3:1. Protocol guided Cohort A N = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%). Acetic acid Cohort B N = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett’s surveillance. Abstract OC-046 Table 1 Protocol biopsies cohort(Cohort A) AAC cohort(Cohort B) N=655 N=327 Gain p value HGD 7/655(1.0%) 18/327 (5.5%) 5.5 fold 0.0001 T1 Cancers 3/655 (0.4%) 14/327 (4.2%) 10 fold 0.0001 Total 10/655 (1.5%) 32/327 (9.7%) 6.5 fold 0.0001 Conclusion This is the first report from a large exclusively Barrett’s surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett’s surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett’s surveillance. Disclosure of Interest None Declared]]></description><subject>Acetic acid</subject><subject>Acids</subject><subject>Barrett's esophagus</subject><subject>Biopsy</subject><subject>Dysplasia</subject><subject>Gastroscopy</subject><subject>Statistical analysis</subject><subject>Surveillance</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNo9kc1u1DAUhSMEEkPhFZAl1inXP3Gc5RCgLapamKlgaXlsz-DBiVPbGTG7bngIeLw-CRkFsbqL8-kcXX1F8RrDOcaUv92Ned_7kgCmJQXWQH0OrHpSLDDjoqREiKfFAgDXZVWz5nnxIqU9AAjR4EXx57YtgfHHh19LbbPTaKmdQe33GLqQdBiOaO12vds6rfrsj-iqG2I42IRubBi8Sk6h9zZbnV3o0UrlKVEJ6dANKlqDckCttwfrVT-1etdPC59jyEEHj8wYXb9D71SMNufHh99rtB7jwTo_4dq-LJ5tlU_21b97Vtx9_HDXXpbXtxdX7fK63GAQvGyM5qphuq422jRAaFMZbBpmOCHWWK3x1mAg1YZgUtUUMDfMsK3glQDOOD0r3sy102P3o01Z7sMY-2lREqCi5oLSE1XOlEvZ_pRDdJ2KR6niD8lrWlfy5msrP63ab5eriy8SJh7P_Kbb_6cxyJMxORuTJ2NyNiYnY_QvHg-NiQ</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Bhattacharyya, R</creator><creator>Tholoor, S</creator><creator>Longcroft-Wheaton, G</creator><creator>Basford, P</creator><creator>Cowlishaw, D</creator><creator>Poller, D</creator><creator>Bhandari, P</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201306</creationdate><title>OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance</title><author>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1086-9dc6a94c75bcd902395d1d94d622edecc1fd1025b212573016d4d4f865806463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetic acid</topic><topic>Acids</topic><topic>Barrett's esophagus</topic><topic>Biopsy</topic><topic>Dysplasia</topic><topic>Gastroscopy</topic><topic>Statistical analysis</topic><topic>Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhattacharyya, R</creatorcontrib><creatorcontrib>Tholoor, S</creatorcontrib><creatorcontrib>Longcroft-Wheaton, G</creatorcontrib><creatorcontrib>Basford, P</creatorcontrib><creatorcontrib>Cowlishaw, D</creatorcontrib><creatorcontrib>Poller, D</creatorcontrib><creatorcontrib>Bhandari, P</creatorcontrib><collection>Istex</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhattacharyya, R</au><au>Tholoor, S</au><au>Longcroft-Wheaton, G</au><au>Basford, P</au><au>Cowlishaw, D</au><au>Poller, D</au><au>Bhandari, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2013-06</date><risdate>2013</risdate><volume>62</volume><issue>Suppl 1</issue><spage>A20</spage><pages>A20-</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><abstract><![CDATA[Introduction Cost effectiveness of Barrett’s surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett’s oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett’s surveillance. Methods Prospective Cohort study comparing two different Barrett’s surveillance strategies. All patients who underwent Barrett’s surveillance between 2008–12 were recorded on a Barrett’s database. All neoplasias were independently reviewed by two GI Pathologists. Barrett’s surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett’s. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher’s exact test was used for statistical analysis. Results N = 982 Barrett’s surveillance gastroscopy between 2008–12. Median age was 66 years & Median Barrett’s length was 4.5 cm (range: 1–20). Male: Female = 3.3:1. Protocol guided Cohort A N = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%). Acetic acid Cohort B N = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett’s surveillance. Abstract OC-046 Table 1 Protocol biopsies cohort(Cohort A) AAC cohort(Cohort B) N=655 N=327 Gain p value HGD 7/655(1.0%) 18/327 (5.5%) 5.5 fold 0.0001 T1 Cancers 3/655 (0.4%) 14/327 (4.2%) 10 fold 0.0001 Total 10/655 (1.5%) 32/327 (9.7%) 6.5 fold 0.0001 Conclusion This is the first report from a large exclusively Barrett’s surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett’s surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett’s surveillance. Disclosure of Interest None Declared]]></abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><doi>10.1136/gutjnl-2013-304907.045</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-5749 |
ispartof | Gut, 2013-06, Vol.62 (Suppl 1), p.A20 |
issn | 0017-5749 1468-3288 |
language | eng |
recordid | cdi_proquest_journals_2038768336 |
source | Open Access: PubMed Central; BMJ Journals Online Archive |
subjects | Acetic acid Acids Barrett's esophagus Biopsy Dysplasia Gastroscopy Statistical analysis Surveillance |
title | OC-046 Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett’S Surveillance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A19%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_istex&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OC-046%E2%80%85Acetic%20Acid%20Chromoscopy%20Significantly%20Improves%20Neoplasia%20Detection%20Rates%20as%20compared%20to%20Cleveland%20Clinic%20Protocol%20during%20Barrett%E2%80%99S%20Surveillance&rft.jtitle=Gut&rft.au=Bhattacharyya,%20R&rft.date=2013-06&rft.volume=62&rft.issue=Suppl%201&rft.spage=A20&rft.pages=A20-&rft.issn=0017-5749&rft.eissn=1468-3288&rft_id=info:doi/10.1136/gutjnl-2013-304907.045&rft_dat=%3Cproquest_istex%3E2038768336%3C/proquest_istex%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038768336&rft_id=info:pmid/&rfr_iscdi=true |